Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma
Clinical trial NCT03788291 · COMPLETED
Trial details
- NCT number
- NCT03788291
- Sponsor
- University of Rochester
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-25
- Primary completion
- 2023-05-19
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.